Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Hearing Loss × Drug Therapy × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 130 Breast Neoplasms 83 Colorectal Neoplasms 66 Neoplasms 54 Stomach Neoplasms 46 Lung Neoplasms 46 Neoplasm Metastasis 43 Pancreatic Neoplasms 41 Ovarian Neoplasms 38 Rectal Neoplasms 37 Esophageal Squamous Cell Carcinoma 35 Esophageal Neoplasms 30 Squamous Cell Carcinoma of Head and Neck 28 Head and Neck Neoplasms 28 Leukemia, Myeloid, Acute 25 Triple Negative Breast Neoplasms 21 Recurrence 21 Colonic Neoplasms 20 Small Cell Lung Carcinoma 19 Precursor Cell Lymphoblastic Leukemia-Lymphoma 19 Nasopharyngeal Carcinoma 19 Lymphoma 17 Glioblastoma 17 Fallopian Tube Neoplasms 17 Uterine Cervical Neoplasms 16 Prostatic Neoplasms 16 Lymphoma, Non-Hodgkin 16 Sarcoma 15 Carcinoma, Squamous Cell 14 Melanoma 13

Interventions

sodium thiosulfate 2 ebselen 2 Ankle Brachial Index 2 Acetylcysteine 2 Tomography, X-Ray Computed 1 Sodium Chloride 1 Saline Solution 1 Ringer's Lactate 1 Radiotherapy 1 Radiosurgery 1 Ofloxacin 1 Magnetic Resonance Imaging 1 Hyaluronic Acid 1 Hearing Tests 1 Ear Protective Devices 1 Drug Therapy 1 Chemoradiotherapy 1 Carboplatin 1 Audiometry, Pure-Tone 1 Atorvastatin 1 Acoustic Impedance Tests 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06551857 2025-04-16

CaSPiN

Turku University Hospital

Ototoxicity, Neoplasms, Hearing Loss, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon ⚡